Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346046 · ClinicalTrials.gov registry record
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2
A clinical trial, sponsored by VeraLight.
- Completed
- Registry status
- 264
- Enrollment target
NCT01346046: Completed study, sponsored by VeraLight.
NCT01346046 is a clinical trial that has completed, run by VeraLight. The registered enrollment target is 264 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01346046 has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 264 participants
- Enrollment target
Study Summary
The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.
Primary Outcome
Collect SCOUT DS and Hemoglobin A1c measurements of subjects with Type 2 Diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-08 |
What the finished NCT01346046 record still lists
NCT01346046 is an observational study that tracks outcomes without assigning an intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01346046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01346046 about?
NCT01346046 is a clinical study titled "Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2". The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.
What is the current status of trial NCT01346046?
This trial is currently completed. The enrollment target is 264 participants. The study started on 2011-05. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01346046?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia